These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 17133077)

  • 1. Update on Clostridium difficile associated disease.
    Cloud J; Kelly CP
    Curr Opin Gastroenterol; 2007 Jan; 23(1):4-9. PubMed ID: 17133077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of Clostridium difficile-associated disease in North America and Europe.
    Kuijper EJ; Coignard B; Tüll P; ; ;
    Clin Microbiol Infect; 2006 Oct; 12 Suppl 6():2-18. PubMed ID: 16965399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New trends in Clostridium difficile virulence and pathogenesis.
    Denève C; Janoir C; Poilane I; Fantinato C; Collignon A
    Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S24-8. PubMed ID: 19303565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridium difficile: changing epidemiology and new treatment options.
    Kuijper EJ; van Dissel JT; Wilcox MH
    Curr Opin Infect Dis; 2007 Aug; 20(4):376-83. PubMed ID: 17609596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on the changing epidemiology of Clostridium difficile-associated disease.
    McFarland LV
    Nat Clin Pract Gastroenterol Hepatol; 2008 Jan; 5(1):40-8. PubMed ID: 18174906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain.
    O'Connor JR; Johnson S; Gerding DN
    Gastroenterology; 2009 May; 136(6):1913-24. PubMed ID: 19457419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidemic risk of disease associated with a new strain of Clostridium difficile].
    Arteaga A; Santa-Olalla P; Sierra MJ; Limia A; Cortés M; Amela C
    Enferm Infecc Microbiol Clin; 2009 May; 27(5):278-84. PubMed ID: 19386385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of the changing face of Clostridium difficile disease for health care practitioners.
    McFarland LV; Beneda HW; Clarridge JE; Raugi GJ
    Am J Infect Control; 2007 May; 35(4):237-53. PubMed ID: 17482995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Québec.
    Hubert B; Loo VG; Bourgault AM; Poirier L; Dascal A; Fortin E; Dionne M; Lorange M
    Clin Infect Dis; 2007 Jan; 44(2):238-44. PubMed ID: 17173224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clostridium-difficile-associated infections].
    Eckert C; Barbut F
    Med Sci (Paris); 2010 Feb; 26(2):153-8. PubMed ID: 20188046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium difficile-associated diarrhoea.
    Elliott B; Chang BJ; Golledge CL; Riley TV
    Intern Med J; 2007 Aug; 37(8):561-8. PubMed ID: 17640189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renewed interest in a difficult disease: Clostridium difficile infections--epidemiology and current treatment strategies.
    McFarland LV
    Curr Opin Gastroenterol; 2009 Jan; 25(1):24-35. PubMed ID: 19114771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078.
    Goorhuis A; Bakker D; Corver J; Debast SB; Harmanus C; Notermans DW; Bergwerff AA; Dekker FW; Kuijper EJ
    Clin Infect Dis; 2008 Nov; 47(9):1162-70. PubMed ID: 18808358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium difficile and the disease it causes.
    Norén T
    Methods Mol Biol; 2010; 646():9-35. PubMed ID: 20597000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007].
    Poilane I; Fantinato C; Cruaud P; Collignon A
    Pathol Biol (Paris); 2008; 56(7-8):412-6. PubMed ID: 18842360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The changing face of Clostridium difficile: what treatment options remain?
    Shen EP; Surawicz CM
    Am J Gastroenterol; 2007 Dec; 102(12):2789-92. PubMed ID: 18042108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.
    Pépin J; Valiquette L; Gagnon S; Routhier S; Brazeau I
    Am J Gastroenterol; 2007 Dec; 102(12):2781-8. PubMed ID: 17900327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on Clostridium difficile infection.
    O'Donoghue C; Kyne L
    Curr Opin Gastroenterol; 2011 Jan; 27(1):38-47. PubMed ID: 21099432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium difficile--a continually evolving and problematic pathogen.
    Dawson LF; Valiente E; Wren BW
    Infect Genet Evol; 2009 Dec; 9(6):1410-7. PubMed ID: 19539054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe.
    Warny M; Pepin J; Fang A; Killgore G; Thompson A; Brazier J; Frost E; McDonald LC
    Lancet; 2005 Sep 24-30; 366(9491):1079-84. PubMed ID: 16182895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.